**Core Concept**
Low molecular weight heparin (LMWH) is a type of anticoagulant medication that primarily inhibits the coagulation cascade by targeting specific clotting factors. Its mechanism of action is distinct from unfractionated heparin, which affects multiple clotting factors.

**Why the Correct Answer is Right**
LMWH mainly inhibits factor Xa, which is a critical component of the coagulation cascade. Factor Xa plays a central role in the conversion of prothrombin to thrombin, a potent enzyme that promotes clot formation. By inhibiting factor Xa, LMWH effectively reduces the formation of thrombin and subsequent clot development. This action is mediated through the release of antithrombin, a naturally occurring anticoagulant that binds to and inactivates factor Xa.

**Why Each Wrong Option is Incorrect**
**Option A:** Factor IIa is actually the target of thrombin inhibitors, such as argatroban, not LMWH. LMWH does not primarily inhibit factor IIa.
**Option B:** Factor V is a clotting factor that is activated by factor Xa, but LMWH does not directly inhibit factor V. Its primary target is factor Xa.
**Option C:** Factor VIIa is involved in the initiation of the coagulation cascade, but LMWH does not primarily inhibit factor VIIa. Its primary target is factor Xa.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that LMWH has a more predictable anticoagulant response compared to unfractionated heparin, making it a safer option for outpatient use.

**Correct Answer:** D. Factor Xa.